Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Chronic kidney disease stories

May 30, 2026

Mineralys Therapeutics' Experimental Drug Significantly Reduces Blood Pressure in Chronic Kidney Disease Patients

Mineralys Therapeutics presented new data at a major European medical conference showing their experimental pill significantly reduced blood pressure in patients with chronic kidney disease.

May 30, 2026·1 source
00

Top claims

  • ▪About 71% of chronic kidney disease patients in the lorundrostat trial were taking three or more blood pressure drugs at baseline.
  • ▪Hypertension affects about 1.4 billion people worldwide.
  • ▪Lorundrostat cut levels of albumin protein in urine by more than half in a subgroup of chronic kidney disease patients who had elevated levels.

Topics

Cardiovascular diseases

Featured Stories

OpenAI pauses development of Astra AI model over critical cybersecurity capability concerns

OpenAI pauses development of Astra AI model over critical cybersecurity capability concerns

Aug 7, 2026·2 sources